Abstract
We examined whether trained women exhibit similar cardiovascular and cardiac baroreflex alterations after a half-marathon compared to men. Thirteen women (39.1 ± 9.3 years; 165 ± 6 cm; 58.2 ± 7.5 kg; maximal aerobic speed (MAS): 13.7 ± 2.2 km·h−1) and 12 men (45.7 ± 10.5 years; 178 ± 7 cm; 75.0 ± 8.3 kg; MAS: 15.8 ± 2.2 km·h−1) ran an official half-marathon. Before and 60-min after, cardiovascular variables, parasympathetic (heart rate variability analysis) modulation and cardiac baroreflex function (transfer function and sequence analyses) were assessed during supine rest and a squat-stand test. Running performance was slower in women than in men (120 ± 19 vs. 104 ± 14 min for women and men, respectively). However, when expressed as a percentage of MAS, it was similar (78.1 ± 4.6% and 78.2 ± 5.4% of MAS for women and men, respectively). Before the run, women exhibited lower mean blood pressure (BP), cardiac output (CO) and stroke volume (SV) compared to men, together with higher parasympathetic indexes. After the race, parasympathetic indexes decreased in both sexes, but remained higher in women. Reduced SV, systolic BP and cardiac baroreflex were observed in men but not in women. Contrary to men, a competitive half-marathon did not trigger post-exercise hypotension and a reduced cardiac baroreflex in women.
Highlights
Cardiovascular disease (CVD) is the leading cause of mortality amongst women worldwide [1,2], making the reduction of CVD risk a crucial factor in reducing mortality [3]
Respectively) were significantly reduced compared to men (178.3 ± 6.7 cm and 75.0 ± 8.3 kg, Both women and men were normal-weight according to their body mass index values, the values being, respectively)
Our results showed that a competitive 21-km run did not trigger post-exercise hypotension during supine rest or during a dynamic task designed to challenge blood pressure (BP) control mechanisms via orthostatic stress (5-min repeated squat stand test) in women
Summary
Cardiovascular disease (CVD) is the leading cause of mortality amongst women worldwide [1,2], making the reduction of CVD risk a crucial factor in reducing mortality [3]. Public Health 2020, 17, 6337; doi:10.3390/ijerph17176337 www.mdpi.com/journal/ijerph
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have